Chris Viehbacher

Chris Viehbacher (born 1960) is a German-Canadian businessman. He served as the Chief Executive Officer of Sanofi and Chairman of Genzyme until 29 October 2014. Viehbacher then worked with Gurnet Point Capital, a healthcare venture capital and private equity fund backed by Ernesto Bertarelli and his family. He joined Biogen as President and Chief Executive Officer and member of the Board of Directors in November 2022. Early life Chris Viehbacher was born on March 26, 1960. He graduated from Queen's University in Kingston, Ontario, Canada. He is a certified public accountant, and he speaks French, German and English. Career Viehbacher started his career at PriceWaterhouseCoopers. In 1988, he joined GlaxoSmithKline, where he worked for the next twenty years, including in France for ten years. Until October 29, 2014, he served as CEO of Sanofi and Chairman of Genzyme. He was fired by unanimous decision of the board of directors in 2014. In 2022, Viehbacher joined Biogen as President and Chief Executive Officer.